April 30th 2024
Learn more about the in-depth topics covered in the April 2024 print issue of Dermatology Times.
Dermatology Times is looking back on the top stories in dermatology from the month of April.
Dermatology Times is recapping our top expert interviews from the month of April.
April 29th 2024
A study found that in addition, recovery time was both quick and yielded minimal symptoms.
April 27th 2024
Keep up with the latest headlines in dermatology from the past week, including the appointment of All Detergent's first chief dermatology advisor, Incyte's acquisition of Escient Pharmaceuticals, and more.
The Weekly Roundup: April 22-26
ICYMI, this week we had news about a study of upadacitinib versus dupilumab in atopic dermatitis, the European Union's approval of bimekizumab for HS, and more.
Colorimetric Scale Offers Practical Classification in Clinical Assessment of Skin of Color
Skin cancer risk classification lacks reliability for darker skin tones and fails in evaluating cutaneous medical conditions or cosmetic interventions, according to creators of the scale.
Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and Workers
In online discussion April 23, commissioners cited health care specifically among their reasons for supporting the ban.
Retinoic Acid, Vitamin A Demonstrates Role in Regulating Hair Follicles and Epidermal Stem Cells
In vitro studies demonstrated that retinoic acid aids stem cells in transitioning away from a state of flexibility in wound healing.
From Earth to Skin: Reviewing the Role of Environmental Factors in Dermatologic Conditions
This Earth Day, we are reviewing studies and research linking the role of the environment with various skin conditions.
Derm In The News: April 14-20
Keep up with the latest headlines in dermatology from the past week, including health alerts and warnings of counterfeit Botox in several states, Washington state's first clinic with radiation therapy for nonmelanoma skin cancer, and more
Tracee Blackburn, PA-C: Gut Health for Healthy Skin
Blackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.
Introducing Omar Noor, MD, FAAD: Dermatology Times' Newest Editorial Advisory Board Member
Noor, the co-owner of Rao Dermatology, shares about his interests in dermatology and what he most looks forward to as a member of our board.
Pointers With Portela: Minimalist Skin Care Routines
In this week’s Pointers With Portela, the 208SkinDoc discusses the effectiveness of a minimalist anti-aging skin care routine for patients.
New Dermatology Social Comparison Scale Demonstrates Acceptable Psychometrics for Clinical and Research Applications
Researchers recently developed and validated the 3-question social comparison scale, which may be applicable outside of conditions such as eczema and psoriasis.
Experts Pen 12 Implementable Steps For Addressing Gender Inequity In Academic Dermatology
Addressing gender inequity in academic dermatology involves strengthening societies, celebrating female dermatologists, promoting leadership, and equitable representation, authors wrote.
A Novel Approach to Distinguishing Scabies From Atopic Dermatitis
The WHO underscores the significance of addressing scabies as a neglected skin disease, especially in regions with limited health care access.
In Interim Analysis, Mogamulizumab Demonstrates Improvements In Mycosis Fungoides, Sézary Syndrome
Interim findings from the PROSPER study of mogamulizumab in adults with CTCL were recently presented orally.
Dermatology Residency Programs Lack Specific, Comprehensive Education on Sensitive Skin
Research from the GW School of Medicine and Health Sciences was recently published in the Journal of Drugs in Dermatology.
Partner Q&A: Spherix Global Insights' Role in Shaping the Future of Dermatology
Dermatology Times is pleased to introduce one of our newest partners, Spherix Global Insights. Learn more about their vision and plans to leverage knowledge to support dermatology.
Derm In The News: April 7-13
Keep up with the latest headlines in dermatology from the past week, including UK efforts to address skin cancer disparities in skin of color, efficacy of a "virtual biopsy," and more.
The Weekly Roundup: April 8-12
ICYMI, this week we had news about Rosacea Awareness Month, topical pravibismane in diabetic foot ulcer infections, and more.
Meet the Spring Editor in Chief: Aaron Farberg, MD
Dermatology Times is pleased to introduce our Spring Editor in Chief, Aaron Farberg, MD, with a snapshot of his involvement in the dermatology space.
Journal Digest: April 8
This week’s collection of the latest dermatologic studies covers circulating tumor DNA in advanced cSCC, targeting IL-13 with tralokinumab in AD, a pediatric lymphoplasmocytic plaque case report, and skin of color reporting in randomized controlled trials focusing on SCC.
Springing Into the Latest Research in Dermatology
In an introduction to our April publication, explore an overview of topics covered in this issue and an introduction to our Spring Editor in Chief, Aaron Farberg, MD.
Phase 1b Data for Topical Pravibismane in Diabetic Foot Ulcer Infection Demonstrates Favorable Effects and Safety
Data was recently published in the International Wound Journal supporting positive outcomes in moderate or severe ulcers.
Derm In The News: March 31-April 6
Keep up with the latest headlines in dermatology from the past week, including the launch of an expanded job board for dermatology support roles, CMS and Incyte's collaboration for povorcitinib in China and Southeast Asia, and more.
The Weekly Roundup: April 1-5
ICYMI, this week we had news about Ycanth's J-code launch, highlights from Diversity in Dermatology, bimekizumab's accepted sBLA for HS, and more.
Increased Levels of B-Type Natriuretic Peptide May be Associated With Various Types of Chronic Itch
Gil Yosipovitch, MD, discusses the correlation between increased BNP levels and chronic pruritus of unknown origin.
Topical Permethrin Demonstrates Lack of Efficacy Compared to Benzyl Benzoate in Most Scabies Cases
In a comparative study, benzyl benzoate demonstrated superior efficacy in scabies cases, while topical permethrin exhibited a lack of effectiveness.
Omalizumab for Chronic Spontaneous Urticaria Does Not Yield Negative Maternal, Fetal Outcomes in Pregnancy
Researchers reviewed the efficacy and safety of omalizumab in patients with severe CSU in a routine clinical practice setting.
Journal Digest: April 4
This week’s collection of the latest dermatologic studies covers topical permethrin 5% vs. benzyl benzoate 25% for scabies, the safety of omalizumab in CSU during pregnancy, symptoms of cognitive impairment in children with AD, and the ethics of cosmetic overtreatment.
New Data on Retinol: Patricia Farris, MD, Shares Insights on Anti-Aging
In this study, topical 0.1% retinol significantly improved crow’s feet, facial wrinkles, uneven skin tone, brown spots, and overall photoaging.
Pointers With Portela: Effects of Hormone Changes on the Skin
In this week’s Pointers With Portela, the 208SkinDoc reviews how the skin is affected during hormonal changes and menopause.
Pelthos Therapeutics Launches to Accelerate Commercialization of Treatment for Molluscum Contagiosum
The new launch is set to bring berdazimer topical gel, 10.3% to adults and pediatric patients over the age of 1 with molluscum contagiosum faster.